Antikor Biopharma
PrivateLast Round
Grant
Nov 1, 2024
Total Funding Raised
$1.51M
Company Overview
Antikor Biopharma is a biotechnology company that specializes in the discovery and development of small-format Antibody Fragment Drug Conjugates (FDCs) for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antikor Biopharma Comparables
Compare Antikor Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Crescendo Biologics Ltd. | 75% | |
| Avacta Group | 70% | |
| Bicycle Therapeutics | 69% | |
Antikor Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2024 | ||||
| Grant | Apr 1, 2022 | ||||
| VC Round | Jul 31, 2019 |
Key People
Founding team and executive leadership
Antikor Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Essex Bio-Technology | VC Round |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2024
$630K raised from Innovate UK.
- Apr 1, 2022
Secured $1.51M in grant funding from Innovate UK.
Antikor Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Antikor Biopharma's valuation, stock price, and market status.